Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04822181
Other study ID # NN9931-4553
Secondary ID U1111-1244-36782
Status Recruiting
Phase Phase 3
First received
Last updated
Start date April 1, 2021
Est. completion date April 25, 2029

Study information

Verified date June 2024
Source Novo Nordisk A/S
Contact Novo Nordisk
Phone (+1) 866-867-7178
Email clinicaltrials@novonordisk.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Semaglutide is a medicine studied in patients with NASH. Semaglutide is a well-known medicine, which is already used by doctors to treat type 2 diabetes in many countries. Participants will either get semaglutide or a dummy medicine - which treatment participants get is decided by chance. Participants will need to inject themselves with medicine under the skin. Participants will need to do this once a week. The study will last for about 5 years. Participants will have up to 21 clinic visits and 9 phone calls with the clinical staff during the study. Some of the clinic visits may be spread over more than one day. Participants with other chronic liver diseases cannot take part in this study. Women cannot take part in the study if they are pregnant, breast-feeding or plan to become pregnant during the study period.


Recruitment information / eligibility

Status Recruiting
Enrollment 1200
Est. completion date April 25, 2029
Est. primary completion date April 25, 2029
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age above or equal to 18 years at the time of signing informed consent. - Histological evidence of NASH based on a central pathologist evaluation of the baseline liver biopsy. The baseline liver biopsy can be a historical biopsy obtained within 180 days prior to the screening visit (V1). - Histological evidence of fibrosis stage 2 or stage 3 according to the NASH CRN (Clinical Research Network) classification based on a central pathologist evaluation of the baseline liver biopsy. - A histological NAS (Non-alcoholic fatty liver disease Activity Score) above or equal to 4 with a score of 1 or more in steatosis, lobular inflammation and hepatocyte ballooning based on a central pathologist evaluation of the baseline liver biopsy. Exclusion Criteria: - Documented causes of chronic liver disease other than non-alcoholic fatty liver disease (NAFLD) - Positive HBsAg, positive anti-HIV, positive HCV RNA at screening (V2A) or any known presence of HCV RNA or HBsAg within 2 years of screening (V2A). - Presence or history of ascites, variceal bleeding, hepatic encephalopathy, spontaneous bacterial peritonitis or liver transplantation at randomisation. - Known or suspected excessive consumption of alcohol (greater than 20 g/day for women or greater than 30 g/day for men) or alcohol dependence (assessed by the Alcohol Use Disorders Identification Test (AUDIT questionnaire)). - Treatment with vitamin E (at doses greater than or equal to 800 IU/day) or pioglitazone or medications approved for treatment of NASH which has not been at a stable dose in the period from 90 days prior to the screening visit (V2A). In addition, for subjects with historical liver biopsies taken more than 90 days prior to screening, treatment should be at a stable dose from time of biopsy until screening. - Treatment with GLP-1 RAs in the period from 90 days prior to the screening visit (V2A). In addition, for subjects with historical liver biopsies taken more than 90 days prior to screening, any treatment with GLP-1 RAs from time of biopsy until screening (V2A). - Treatment with glucose-lowering agent(s) (other than GLP-1 RAs), lipid-lowering medication or weight loss medication not stable in the opinion of the investigator in the period from 90 days prior to the screening visit (V2A). In addition, for subjects with historical liver biopsies taken more than 90 days prior to screening, treatment should be at a stable dose in the opinion of the investigator from time of biopsy until screening.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Semaglutide
Semaglutide administrated subcutaneously (under the skin) once weekly there will be a period of dose escalation before reaching the target dose.
Placebo
Placebo administrated subcutaneously (under the skin) once weekly.

Locations

Country Name City State
Argentina DIM Clinica Privada Buenos Aires
Argentina Centro Médico Viamonte SRL Caba
Argentina Centro Médico Viamonte SRL Caba
Argentina Glenny Corp. S.A Caba
Argentina Hospital Italiano Departamento Hepatologia Caba
Argentina Centro de Investigaciones Metabólicas Capital Federal
Argentina Hospital Britanico de Buenos Aires Ciudad de Buenos Aires Buenos Aires
Argentina Hospital El Cruce Florencio Varela, Buenos Aires
Argentina Hospital del Centenario Rosario, Santa Fe
Australia Royal Adelaide Hospital - Hepatology- 5E291 Adelaide South Australia
Australia A.W. Morrow Gastroenterology and Liver Centre Camperdown New South Wales
Australia Lyell McEwin Hospital Elizabeth Vale South Australia
Australia St Vincent's Hospital (Melbourne) Fitzroy Victoria
Australia Austin Health Heidelberg Victoria
Australia Nepean Hospital Kingswood New South Wales
Australia Liverpool Hospital Liverpool New South Wales
Australia Fiona Stanley Hospital - Hepatology Murdoch Western Australia
Australia Sir Charles Gairdner Hospital_Nedlands Nedlands Western Australia
Australia Griffith University Clinical Trial Unit Southport Queensland
Australia Westmead Hospital Westmead New South Wales
Austria Klin.Abt. f. Gastroenterologie u. Hepatologie Graz
Austria Fließer-Görzer [Ordination] Saint Stefan
Austria LKH Salzburg Universitätsklinikum Salzburg
Austria Klinikum Wels-Grieskirchen Wels
Austria Klinik Landstraße Wien
Belgium Cliniques Universitaires Saint-Luc - Serv. Hépato-gastroentérology Bruxelles
Belgium CUB Hôpital Erasme_Brussels_0 Bruxelles
Belgium UZA Edegem
Belgium Ziekenhuis Oost-Limburg AV - Gastro Genk
Belgium AZ Maria Middelares - Gent - Gastro-Enterology Gent
Belgium UZ Gent - Department Gastro-enterology Gent
Brazil Fundação Pio XII Barretos São Paulo
Brazil Hospital das Clínicas da Faculdade de Medicina de Botucatu Botucatu Sao Paulo
Brazil Hospital das Clínicas da Universidade Federal de Goiás Goiânia Goias
Brazil Hospital de Clínicas de Porto Alegre_Porto Alegre Porto Alegre Rio Grande Do Sul
Brazil Hospital Universitario Clementino Fraga Filho Rio de Janeiro
Brazil Fundação Bahiana de Infectologia Salvador Bahia
Brazil CIP Centro Integrado de Pesquisas do Hospital de Base São José do Rio Preto Sao Paulo
Brazil Assoc. Paulista para o Desenvolvimento da Medicina - UNIFESP São Paulo Sao Paulo
Brazil Departamento de Gastroenterologia - HCFMUSP São Paulo Sao Paulo
Brazil Rocco e Nazato Servicos Medicos LTDA São Paulo
Bulgaria "MHAT - UniHospital" OOD Panagyurishte
Bulgaria MHAT "Med Line Clinic" Plovdiv
Bulgaria "Acibadem City Clinic UMHAT Tokuda" Sofia
Bulgaria "DCC XX - Sofia" EOOD Sofia
Bulgaria "Diagnostic - Consulting Center Aleksandrovska" EOOD Sofia
Bulgaria "Medical Center Vertebra" Ltd. Sofia
Bulgaria "UMHAT "Sveta Anna" Sofia" AD Sofia
Bulgaria "UMHAT "Tsaritsa Yoanna-ISUL"" EAD, Gastroenterology clinic Sofia
Bulgaria "UMHAT "Tsaritsa Yoanna-ISUL"" EAD, Gastroenterology clinic Sofia
Bulgaria Acibadem City Clinic UMHAT Mladost Sofia
Bulgaria Medical Center Synexus Sofia Sofia
Bulgaria UMHAT "Sv. Ivan Rilski", Clinic of Gastroenterology Sofia
Bulgaria UMHAT "Sveta Marina" Varna
Canada LMC ClinRsrh Inc.Brampton Brampton Ontario
Canada University of Calgary Liver Unit-(HMRC) Calgary Alberta
Canada Ecogene-21 Chicoutimi Quebec
Canada Nova Scotia Hlth Halifax Halifax Nova Scotia
Canada London Hlth Sci Ctr- Univ Camp London Ontario
Canada Clinique Medicine Urbaine du Quartier Latin, Inc. Montreal Quebec
Canada McGill University Health Centre Montreal Quebec
Canada Hospital Fleurimont / CIUSS Sherbrooke Quebec
Canada Ctr de Med Metab de Lanaudiere Terrebonne Quebec
Canada Centricity Research LMC Toronto Ontario
Canada Toronto Liver Centre Toronto Ontario
Canada GI Research Institute Vancouver British Columbia
Canada TDDA Specialty Research Vaughan Ontario
China Beijing Ditan Hospital Capital Medical University Beijing Beijing
China Beijing Friendship Hospital, Capital Medical University Beijing Beijing
China Beijing Tsinghua Changgung Hospital-Hepatology Beijing Beijing
China Beijing You'an Hospital, Capital Medical University Beijing Beijing
China Peking University People's Hospital(White Pagoda Temple Area Beijing Beijing
China The First Bethune Hospital of Jilin University Changchun Jilin
China Hunan Provincial People's Hospital Changsha Hunan
China Hunan Provincial People's Hospital Changsha Hunan
China Changzhou No.2 People's Hospital Changzhou Jiangsu
China West China Hospital, Sichuan University Chengdu
China Three Gorges Hospital Affiliated to Chongqing University Chongqing Chongqing
China Foshan First People's Hospital Foshan Guangdong
China Guangzhou Eighth People's Hospital Guangzhou
China Guangzhou First people's Hospital Guangzhou Guangdong
China Nanfang Hospital, Southern Medical University-1 Guangzhou Guangdong
China The 3rd Affiliated Hosp of Sun Yat-sen University,Infectious Guangzhou Guangdong
China The First Affiliated Hospital , Sun Yat-sen University Guangzhou
China Zhejiang Hospital Hangzhou
China Jinan Central Hospital Ji'nan Shandong
China Liaocheng People's Hospital Liaocheng Shandong
China Liaocheng People's Hospital Liaocheng Shandong
China The First Affiliated Hospital of Nanchang University Nanchang
China The Second Hospital of Nanjing Nanjing Jiangsu
China Qingdao Municipal Hospital (Group) Qingdao Shandong
China Renji Hospital Affiliated to Shanghai Jiaotong University Shanghai Shanghai
China Ruijin Hospital Affiliate to The Shanghai Jiaotong Universit Shanghai Shanghai
China Shanghai Ninth People's Hospital Shanghai Shanghai
China Peking University Shenzhen Hospital Shenzhen Guangdong
China The Third People's Hospital of Shenzhen Shenzhen
China The Third Hospital of Hebei Medical University Shijiazhuang Hebei
China Tianjin Second People's Hospital Tianjin
China Tianjin Third Central Hospital Tianjin Tianjin
China The First Hospital Affiliated to Wenzhou Medical College Wenzhou Zhejiang
China THE Affiliated Hospital of Xuzhou Medical University(East) Xuzhou Jiangsu
China General Hosp of Ningxia Medical University,Infectious Depart Yinchuan Ningxia
China The Third People's Hospital of Zhenjiang Zhenjiang Jiangsu
Croatia Klinicki bolnicki centar Osijek Osijek
Croatia KBC Rijeka, Zavod za gastroenterologiju Rijeka
Croatia KBC Split/ Firule/ Gastroenterologija Split
Croatia KB Dubrava, Zavod za gastroenterologiju Zagreb
Croatia Klinicki bolnicki centar Zagreb, Zavod za gastroenterologiju Zagreb
Czechia Krajská nemocice Liberec, a.s Liberec
Czechia Krajská nemocice Liberec, a.s Liberec
Czechia Fakultni nemocnice Plzen - Lochotin Plzen
Czechia Researchsite s.r.o. Plzen
Czechia Vseobecna Fakultni nemocnice v Praze Prague 2
Czechia Vseobecna Fakultni nemocnice v Praze Prague 2
Denmark Aarhus Universitetshospital Skejby Mave-Tarm Aarhus N
Denmark Hvidovre Hospital Hvidovre
Denmark Abdominal Center K, Research Unit København NV
Denmark Odense University Hospital Odense C
France Centre Hospitalier Universitaire D'Angers-1 Angers
France Ap-Hp-Hopital Beaujon Clichy
France Centre Hospitalier Universitaire de Lille-Hopital Claude Huriez Lille
France Hospices Civils de Lyon-Hopital de La Croix Rousse Lyon Cedex 4
France Centre Hospitalier Universitaire de Nice-Hopital de L'Archet 2 Nice
France Ap-Hp-Hopital Cochin Paris
France Aphp-Hopital La Pitie Salpetriere-4 Paris
France Centre Hospitalier Universitaire de Bordeaux-Hopital Haut Leveque-1 Pessac
France Hospices Civils de Lyon-Hopital Lyon Sud-1 Pierre-Benite
France Les Hopitaux Universitaires de Strasbourg-Hopital Civil-1 Strasbourg Cedex
Germany Charite Universitätsmedizin Berlin, Virchow-Klinikum Berlin
Germany Prof. Dr. Hofmann Wolf-Peter, Berlin Berlin
Germany Medizinsche Klinik - Studienbüro Gastroenterologie & Hepatologie Uniklinik Bochum Bochum
Germany Dr. Lutz Phillip, Bonn Bonn
Germany Hepatologie Universitätsklinikum Frankfurt/M Frankfurt
Germany Medizinische Hochschule Hannover, Hepatologie Hannover
Germany Prof. Dr. Schiefke Ingolf, EUGASTRO GmbH Leipzig
Germany Universitätsklinikum Leipzig, Klinik und Poliklinik Leipzig
Germany Universitätsklinikum Schleswig-Holstein Lübeck
Germany Otto-von-Guericke University - University Clinic for Gastroenterology, Hepatology and Infectology Magdeburg
Germany Universitätsmedizin der Johannes-Gutenberg-Universität Mainz Mainz
Germany Universitätsmedizin Mannheim - Studienambulanz, II.Medizinische Klinik Mannheim
Germany Universitätsklinikum Würzburg, ZIM Würzburg
Greece Gen Hospital of Athens Ippokrateio,B' Uni Clinic of Inte Med Athens
Greece Gen Hospital of Athens Laiko,1st Dpt. of Propaedeutic Inter Athens
Greece General Hospital of Athens "LAIKO" Goudi, Athens
Greece Univ Gen Hospital of Ioannina,Gastroenterology-Endoscopy Uni Ioannina
Greece Univ Gen Hospital Larisa, Cardiology Medicine Clinic Larissa
Greece "AHEPA" University Hospital of Thessaloniki Thessaloniki
Greece AHEPA General University Hospital Thessaloniki
Greece General Hospital of Thessaloniki "Ippokrateio" Thessaloniki
India Post Graduate Institute of Medical Education & Research_Chandigarh Chandigarh Punjab
India All India Institute of medical Sciences Delhi New Delhi
India Medanta - The Medicity Multi-Speciality Hospital, Gurugram Gurgaon Haryana
India Osmania General Hospital_Hyderabad Hyderabad Telangana
India Ramdev Rao Hospital Hyderabad Telangana
India S.R.Kalla Memorial Gastro & General Hospital Jaipur Rajasthan
India SMS Super speciality Hospital, Department of Gastroenterology Jaipur Rajasthan
India MV Hospital and Research Centre Lucknow Uttar Pradesh
India Dayanand Medical College & Hospital Ludhiana Punjab
India Kasturba Medical College Hospitals (KMC Hospitals), Mangalore Mangalore Karnataka
India Fortis Heart Institute and Multispeciality Hospital Mohali Punjab
India Gleneagles Hospital, Super-speciality and Transplant Centre, Parel Mumbai Maharashtra
India Seth GS medical college and KEM Hospital Mumbai Maharashtra
India Midas Multispeciality Hospital Nagpur Maharashtra
India Fortis Escort Heart Institute New Delhi
India Institute of liver and Biliary Sciences New Delhi
India Yashoda Hospital Secunderabad Andhra Pradesh
India Yashoda Hospital Secunderabad Andhra Pradesh
India BAPS Pramukh Swami Hospital Surat Gujarat
India Surat Institute of Digestive Science Surat Gujarat
Ireland Beaumont Hospital Dublin
Ireland Hepatology St James's Dublin
Israel Carmel Medical Center Liver Unit Haifa
Israel Liver Unit, Hadassah Medical Center Jerusalem
Israel Shaare Zedek Medical Center Jerusalem
Israel Galil Medical Center, Nahariya, Internal Medicine A Nahariya
Israel Liver Institute, Rabin Medical Center, Beilinson Campuse Petah-Tikva
Israel The Chaim Sheba Medical Center Liver Diseases Center Ramat-Gan
Israel Sourasky Medical Center Liver Unit Tel Aviv
Italy Azieda Ospedaliero-Universitaria, Policlinico S. Orsola-Malp Bologna
Italy Azienda Ospedaliero-Universitaria Renato Dulbecco Catanzaro Cz
Italy AOU Careggi Padiglione 16 San Luca, 3° piano Firenze
Italy Ospedali riuniti di Foggia Foggia
Italy Osp Magg Policlinico Centro Malattie metaboliche del Fegato Milano
Italy AOUP Giaccone Palermo Palermo
Italy Fondazione Policlinico Universitario Agostino Gemelli IRCCS Roma
Italy Policlinico Università Campus Biomedico di Roma Rome
Italy IRCCS Casa Sollievo della Sofferenza San Giovanni Rotondo San Giovanni Rotondo Foggia
Italy Città della salute e della scienza - university of Torino Torino
Japan Juntendo University Hospital, Gastroenterology Bunkyo-ku, Tokyo
Japan The University of Tokyo Hospital, Gastroenterology Bunkyo-ku, Tokyo
Japan Fukui-ken Saiseikai Hospital, Internal Medicine Fukui-shi, Fukui
Japan Hoshi General Hospital_Gastroenterology Fukushima
Japan Gifu Municipal Hospital_Hepatology Gifu
Japan Ogaki Municipal Hospital_Gastroenterology and Hepatology Gifu
Japan Hamamatsu University Hospital Hamamatsu-shi, Shizuoka
Japan JA Hiroshima General Hospital Hatsukaichi-shi, Hiroshima
Japan Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hosp. Hiroshima-shi, Hiroshima
Japan Hiroshima University Hospital Hiroshima-shi, Hiroshima
Japan Juntendo University Shizuoka Hospital Izunokuni-shi, Shizuoka
Japan Kagoshima University Hospital, Gastroenterology Kagoshima-shi, Kagoshima
Japan University Hospital Kyoto Prefectual University of Medicine Kamigyo-ku, Kyoto
Japan Kanazawa University Hospital Kanazawa-shi, Ishikawa
Japan Nara Medical University Hospital_Kashihara-shi, Nara Kashihara-shi, Nara
Japan St. Marianna University School of Medicine Hospital Kawasaki-shi, Kanagawa
Japan Kumamoto Shinto General Hospital Kumamoto-shi, Kumamoto
Japan Toranomon Hospital, Hepatology Minato-ku, Tokyo
Japan Japanese Red Cross Musashino Hospital Musashino-shi, Tokyo
Japan Aichi Medical University Hospital Nagakute-shi, Aichi
Japan Heartlife Hospital Nakagamigun, Okinawa
Japan Nara City Hospital, Gastroenterology and Hepatology Nara-shi, Nara
Japan Hyogo Medical University Hospital_Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine Nishinomiya-shi, Hyogo
Japan Oita Cardiovascular Hospital Oita-shi, Oita
Japan Kawasaki Medical School General Medical Center Okayama-shi, Okayama
Japan Japan Organization of Occupational Health and Safety Osaka Rosai Hospital_Gastroenterology Osaka
Japan Osaka City University Hospital, Department of Hepatology Osaka-shi, Osaka
Japan Otsu City Hospital, Gastroenterological Medicine Otsu-shi, Shiga
Japan Saga University Hospital_Liver Center Saga-shi, Saga
Japan Japan Community Health care Organization Hokkaido Hospital Sapporo-shi, Hokkaido
Japan Sendai Kousei Hospital Sendai-shi, Miyagi
Japan Tokyo Women's Medical University Hospital Shinjuku-ku, Tokyo
Japan Osaka University Hospital, Department of Gastro. & Hepato Suita-shi, Osaka
Japan Saiseikai Suita Hospital, Gastroenterology Suita-shi, Osaka
Japan Kagawa Prefectural Central Hospital Takamatsu-shi, Kagawa
Japan National Hospital Organization Takasaki General Medical Ctr. Takasaki-shi, Gunma
Japan Nihon University Itabashi Hospital Tokyo
Japan Ehime University Hospital Toon-shi, Ehime
Japan Saiseikai Wakayama Hospital Wakayama-shi, Wakayama
Japan Yokohama City University Hospital, Gastrointestinal Medicine Yokohama-shi, Kanagawa
Korea, Republic of Keimyung University Dongsan Medical Center Daegu
Korea, Republic of Kyungpook National University Hospital Daegu
Korea, Republic of Yeungnam Univ. Medical Center Daegu
Korea, Republic of Wonju Severance Christian Hospital Gangwon-do
Korea, Republic of SoonChunHyang University Hospital Bucheon Gyeonggi-do
Korea, Republic of Chung-Ang University Hospital Seoul
Korea, Republic of Korea University Guro Hospital Seoul
Korea, Republic of Severance Hospital, Yonsei University Health System Seoul
Korea, Republic of SMG-SNU Boramae Medical Center Seoul
Malaysia Hospital Selayang Batu Caves
Malaysia Hospital Universiti Sains Malaysia Kota Bharu Kelantan
Malaysia University Malaya Medical Centre Kuala Lumpur Wilayah Persekutuan Kuala Lumpur
Mexico Centro de Investigacion Clinica del Pacifico, S.A. de C.V. Acapulco de Juarez Guerrero
Mexico Centro de Investigación y Gastroenterología, S.C. Ciudad de México México, D.F.
Mexico Hospital Angeles de Culiacan Culiacan Sinaloa
Mexico Centro de Investigación Médico Biológica y Terapia Guadalajara Jalisco
Mexico Medical Care and Research S. A de C.V Merida Yucatan
Mexico Centro de Investigación y Gastroenterología_ Hospital Angeles Universidad Mexico
Mexico Investigaciones Médicas Cisneros, S.C. Monterrey Nuevo León
Mexico Servicios de Oncologia Medica Integral S.A de C.V (ONCARE) San Pedro Garza Garcia Nuevo Leon
Netherlands Noordwest Ziekenhuisgroep Alkmaar
Netherlands Academisch Medisch Centrum Amsterdam
Netherlands Leids Universitair Medisch Centrum Leiden
Netherlands Leids Universitair Medisch Centrum Leiden
Netherlands Franciscus Gasthuis en Vlietland Rotterdam
Norway Bærum sykehus Gjettum
Norway Oslo universitetssykehus, Ullevål Oslo
Poland Gizinscy Centrum Medyczne Bydgoszcz
Poland ID Clinic Arkadiusz Pisula Myslowice Malopolskie
Poland Ko-Med Centra Kliniczne Staszow Staszow Swietokrzyskie
Poland Velocity Nova Sp. z o.o. Staszow
Poland BodyClinic Warszawa
Poland Centrum Badan Klinicznych Wroclaw
Poland FutureMeds Sp. z o.o. Wroclaw
Portugal Hospital Garcia de Orta Almada
Portugal Hospital Infante D. Pedro - Aveiro Aveiro
Portugal Hospital de Braga Braga
Portugal Hospital Sousa Martins - Unidade Local de Saúde de Guarda Guarda
Portugal Hospital da Senhora da Oliveira - Guimarães Guimarães
Portugal APDP - Associação Protectora dos Diabéticos de Portugal Lisboa
Portugal Centro Hospitalar Lisboa Norte Lisboa
Portugal Unidade Local de Saúde de Matosinhos Matosinhos
Portugal Centro Hospitalar de São João Porto
Portugal Unidade Local de Saúde de Santo António, E.P.E Porto
Portugal Unidade Local de Saúde do Alto Minho - Viana do Castelo Viana do Castelo
Portugal Centro Hospitalar Vila Nova de Gaia/Espinho, EPE Vila Nova de Gaia
Portugal Hospital da Luz Arrabida Vila Nova de Gaia
Portugal Centro Hospitalar de Trás-os-Montes e Alto Douro Vila Real
Puerto Rico FDI Clinical Research San Juan
Romania Sana Monitoring SRL Bucharest
Romania Hightech Medical Services S.R.L. Bucuresti
Romania Institutul Clinic Fundeni Bucuresti
Romania Spitalul Universitar de Urgenta Bucuresti Bucuresti
Romania Institutul Gastroenterologie-Hepatologie Cluj-Napoca Cluj-Napoca
Romania Spitalul Clinic CF Cluj Napoca Cluj-Napoca
Romania Gastroenterologie Spitalul Judetean Constanta Constanta
Romania SC Diamed Obesity SRL Galati
Romania Gastromedica Iasi
Romania County Emergency Hospital Satu Mare Satu Mare
Russian Federation Volosevich First City Clinical Hospital Arkhangelsk
Russian Federation City Hospital #5 Barnaul
Russian Federation Kazan Federal University Kazan
Russian Federation LLC "Clinic of Aesthetic Medicine & Laser Technologies" Kazan
Russian Federation Friendship University of Russia Moscow
Russian Federation PHI "Central Clinical Hospital RZD- Medicine" Moscow
Russian Federation Setchenov First Moscow State Medical University Moscow
Russian Federation Limited Law Company "Healthy Family" Medicine Center" Novosibirsk
Russian Federation Penza Regional Clinical Hospital named after N.N. Burdenko Penza
Russian Federation Joint Stock Company "Polyclinic Complex" Saint Petersburg
Russian Federation SPb SBHI City Outpatient clinic #109 Saint Petersburg
Russian Federation Consultative & Diagnostic Center with a Outpatient Hospital Saint-Petersburg
Russian Federation Limited Liability Company "Energiya Zdoroviya" Saint-Petersburg
Russian Federation North-Western State Medical Univer. based on Med-Prof Center Saint-Petersburg
Russian Federation North-Western State Medical Univer. based on Med-Prof Center Saint-Petersburg
Russian Federation Siberian State Medical University Tomsk
Russian Federation Ulianovsk Regional Clinical Hospital Ulianovsk
Russian Federation Polyclinic #2 in Yoshkar-Ola Yoshkar-Ola
Serbia Clinic for gastroenterology and hepatology Belgrade
Serbia Clinical-hospital centre Zvezdara Belgrade
Serbia Endocrinology, Diabetes and Metabolism Diseases Clinic Belgrade
Serbia Clin. Centre Vojvodina, Clin. endocr., diab. and met. dis. Novi Sad Vojvodina
Singapore Changi General Hospital Singapore
Singapore National University Hospital_TBD Singapore
Singapore National University Hospital_TBD Singapore
Singapore Singapore General Hospital Singapore
Slovakia Diabetologická ambulancia - Nemocnica akademika L. Derera, UNB Bratislava
Slovakia MEDISPEKTRUM s.r.o. Bratislava
Slovakia II. Interna klinika, Univerzitna nemocnica L. Pasteura Kosice Kosice
Slovakia Hepatobiliarne centrum - Michalovce Michalovce
Slovakia JAL s.r.o. Trnava
South Africa Dr Rajabally's Practice Cape Town Western Cape
South Africa Tiervlei Trial Centre Cape Town Western Cape
South Africa Maxwell Centre Durban KwaZulu-Natal
South Africa Maxwell Centre Durban KwaZulu-Natal
South Africa Chris Hani Baragwanath Hospital Johannesburg Gauteng
South Africa Chris Hani Baragwanath Hospital Johannesburg Gauteng
South Africa WITS Clinical Research Johannesburg Gauteng
South Africa Wits Health Consortium Johannesburg
South Africa Lenasia Clinical Trial Centre Lenasia Gauteng
South Africa Phoenix Pharma Port Elizabeth Eastern Cape
Spain Hospital Vall d'Hebron Barcelona
Spain Hospital Universitario Puerta de Hierro Majadahonda Majadahonda
Spain Complejo Hospitalario de Pontevedra - Hospital de Montecelo Pontevedra
Spain Complejo Hospitalario de Pontevedra - Hospital de Montecelo Pontevedra Galicia
Spain Hospital Universitario Marqués de Valdecilla Santander
Spain Hospital Universitario Virgen del Rocío Sevilla
Spain Hospital General de Valencia Valencia
Spain Hospital Universitario y Politécnico La Fe Valencia
Spain Hospital Clínico de Valladolid Valladolid
Switzerland Universitätsklinik für Viszerale Chirurgie und Medizin Bern
Switzerland Hôpitaux Universitaires de Genève Geneva
Switzerland Hôpitaux Universitaires de Genève Geneva
Switzerland Kantonsspital Olten Olten
Switzerland Kantonsspital St. Gallen St. Gallen
Switzerland USZ Klinik für Gastroenterologie und Hepatologie Zürich
Taiwan Ditmanson Medical Foundation Chia-Yi Christian Hospital Chiayi City
Taiwan Kaohsiung Medical University Chung-Ho Memorial Hospital Kaoshiung
Taiwan Taipei Tzu Chi Hospital New Taipei City
Taiwan China Medical University Hospital Taichung
Taiwan National Cheng Kung University Hospital Tainan City
Taiwan Cathay General Hospital Taipei
Taiwan Mackay Memorial Hospital- Taipei Taipei
Taiwan National Taiwan University Hospital Taipei
Taiwan Taipei Medical University Hospital Taipei city
Taiwan Taipei-Veterans General Hospital - Dept of Gastrointestinal Taipei city
Turkey T.C. Saglik Bakanligi Adana Sehir Egitim ve Arastirma Hastan Adana
Turkey Ankara Sehir Hastanesi,Gastroenteroloji Klinigi Ankara
Turkey Ankara Universitesi Tip Fakultesi Gastroenteroloji Bilim Da Ankara
Turkey Hacettepe Universitesi Tip Fakültesi- Gastroenteroloji Ankara
Turkey Uludag Universitesi Tip Fakultesi-Gastroenteroloji Bursa
Turkey Bezmialem Vakif Universitesi Tip Fakultesi Hastanesi-Gastroe Istanbul
Turkey Istanbul Universitesi Istanbul Tip Fakultesi-Gastroenterolog Istanbul
Turkey Koc Universitesi Hastanesi-Gastroenteroloji Istanbul
Turkey Marmara Univ. Pendik Gastroenterology Istanbul
Turkey Umraniye Egitim ve Arastirma Hastanesi, Gastroenteroloji Istanbul
Turkey Ege Universitesi Tip Fakultesi Hastanesi, Gastroenteroloji Izmir
Turkey Ege Universitesi Tip Fakultesi Hastanesi, Gastroenteroloji Izmir
Turkey Kocaeli Universitesi Tip Fakültesi Gastroenteroloji ve Hepat Kocaeli
Turkey Mersin Universitesi Tip Fakultesi Gastroenteroloji Bilim Dal Mersin
United Kingdom Royal Victoria Hospital Belfast
United Kingdom New Queen Elizabeth Hospital Birmingham Birmingham
United Kingdom WISDEM Centre Coventry
United Kingdom Royal Derby Hospital Derby
United Kingdom Ninewells Hospital Dundee
United Kingdom Royal Devon University Healthcare NHS Foundation Trust Exeter
United Kingdom Hull Royal Infirmary_Hull Hull
United Kingdom The Diabetes Centre Ipswich
United Kingdom St. James University Hospital Leeds
United Kingdom Chelsea & Westminster Hospital London
United Kingdom Imperial College London London
United Kingdom Liver Research London
United Kingdom Royal Free - Immunity & Transplantation London
United Kingdom Royal London Hospital_London London
United Kingdom Freeman Hospital, Newcastle Newcastle-Upon Tyne
United Kingdom Nottingham University Hospital Nottingham
United Kingdom John Radcliffe Hospital Oxford
United Kingdom Derriford Hospital Plymouth
United Kingdom Northern General Hospital Sheffield
United Kingdom Southampton General Hospital Southampton
United Kingdom Joint Clinical Research Facility - Swansea Swansea
United States Amarillo Center for Clinical Research, Ltd. Amarillo Texas
United States University of Michigan Medicine Ann Arbor Michigan
United States Texas Clin Res Inst, LLC Arlington Texas
United States Emory University Hospital Atlanta Georgia
United States Mercy Medical Center, GI Research Baltimore Maryland
United States Walter Reed Nat Mil Md Ctr Bethesda Maryland
United States Boston Medical Center_Cary Boston Massachusetts
United States Encore Medical Research of Boynton Beach LLC Boynton Beach Florida
United States OM Research LLC Camarillo California
United States The Institute for Liver Health Chandler Arizona
United States Medical University Of South Carolina Charleston South Carolina
United States AtriumHealth Liver Care, Pineville Charlotte North Carolina
United States University Of Virginia Hospitl Charlottesville Virginia
United States WR-ClinSearch, LLC Chattanooga Tennessee
United States WR-ClinSearch, LLC Chattanooga Tennessee
United States Clinical Research Professionals Chesterfield Missouri
United States Rush University Med. Cntr Chicago Illinois
United States University Of Chicago Chicago Illinois
United States Iowa Digestive Disease Center Clive Iowa
United States Peak Gastro Assoc-Col Springs Colorado Springs Colorado
United States Columbus Regional Research Institute Columbus Georgia
United States Ohio State Univ Wexner Med Ctr Columbus Ohio
United States Northeast GI Research Division Concord North Carolina
United States Clinical Res Collaborative Cumberland Rhode Island
United States Liver Ins@ Mthdist DTX Med Cen Dallas Texas
United States UT Southwestern Med Cntr Dallas Texas
United States Velocity Clinical Res-Dallas Dallas Texas
United States Geisinger Clinic Danville Pennsylvania
United States Henry Ford Health System Detroit Michigan
United States Integrity Clinical Research, LLC Doral Florida
United States Duke Univ. Med CNTR_Durham_2 Durham North Carolina
United States South Texas Research Institute Edinburg Texas
United States Gastroenterology & Liver Institute Escondido California
United States Inova Fairfax Medical Campus Falls Church Virginia
United States AIG Digestive Disease Research Florham Park New Jersey
United States Covenant Metabolic Specialists, Ft. Myers Fort Myers Florida
United States Brooke Army Medical Ctr. Fort Sam Houston Texas
United States GI Alliance Research Fort Worth Texas
United States University of Florida-CTRB Gainesville Florida
United States Woodholme Gastroenterology Associates Glen Burnie Maryland
United States Shang Wu M.D. Inc. Hacienda Heights California
United States Digestive Health Res-TSMC Hermitage Tennessee
United States Pennsylvania State University Hershey Pennsylvania
United States Direct Helpers Research Center Hialeah Florida
United States Miguel Rebollar PA Hialeah Florida
United States Tandem Clinical Research - Houma Houma Louisiana
United States Amir Ali Hassan, MD, PA Houston Texas
United States Baylor College Of Medicine Houston Texas
United States Biopharma Informatic Houston Texas
United States Bipharma Informatic Inc. Houston Texas
United States Bylr Coll Md-Ben Taub Gen Hos Houston Texas
United States Houston Methodist Hospital Houston Texas
United States Houston Research Institute Houston Texas
United States North AL Health Res, LLC Huntsville Alabama
United States Indiana University Hospital Indianapolis Indiana
United States Southern Therapy and Advanced Research LLC Jackson Mississippi
United States East Tennessee Research Institute Johnson City Tennessee
United States ARcare Center for Clinical Research Jonesboro Arkansas
United States Kansas City Research Institute Kansas City Missouri
United States University Of Kansas Hospital Kansas City Kansas
United States Scripps Whittier Diabetes Inst La Jolla California
United States UCSD NAFLD Research Center La Jolla California
United States Florida Research Institute, LLC Lakewood Ranch Florida
United States OM Research LLC Lancaster California
United States Jubilee Clinical Research, Inc. Las Vegas Nevada
United States Sierra Clinical Research-Las Vegas Las Vegas Nevada
United States Ocean St Clin Res Partnrs, LLC Lincoln Rhode Island
United States Arkansas Diagnostic Center, PA Little Rock Arkansas
United States Digestive Hlth Res of SoCa Long Beach California
United States Gastroenterology Assoc_ CGA Macon Georgia
United States Sandhill Research, LLC Maitland Florida
United States Tandem Clinical Research - Maitland Maitland Florida
United States Gastroint Spec of Georgia Marietta Georgia
United States Tandem Clinical Research Marrero Louisiana
United States Centex Studies - McAllen McAllen Texas
United States Tandem Clinical Research - Metairie Metairie Louisiana
United States Genoma Research Group, Inc Miami Florida
United States IMIC Inc Miami Florida
United States Optimus U, Corp Miami Florida
United States Univ of Miami/Schiff Ctr Miami Florida
United States San Marcus Res Clin Miami Lakes Miami Lakes Florida
United States Quality Medical Research Nashville Tennessee
United States Yale Ctr for Clin Invest New Haven Connecticut
United States Icahn Sch of Med-Mt Sinai Hosp New York New York
United States NYU Grossman School of Med New York New York
United States Weill Cornell Med Coll-NYPH New York New York
United States Digestive and Liver Disease Specialists Norfolk Virginia
United States Ocala GI Research Ocala Florida
United States Sensible Healthcare LLC Ocoee Florida
United States South Ogden Family Medicine/ CCT Research Ogden Utah
United States Univ of Nebraska Medical CTR Omaha Nebraska
United States Cedars-Sinai Medical Center Pasadena California
United States Pasedena Liver Center Pasadena California
United States LinQ Research, LLC Pearland Texas
United States Inst-Liver Hlth dba AZ Liver H Peoria Arizona
United States Thomas Jefferson University Hospital Philadelphia Pennsylvania
United States University of Pennsylvania Hospital Philadelphia Pennsylvania
United States UPMC Center for Liver Diseases Pittsburgh Pennsylvania
United States UPMC_Center for Liver Care Pittsburgh Pennsylvania
United States Care Access Research, Pottsville Pottsville Pennsylvania
United States Inland Empire Clin Trials LLC Rialto California
United States Bon Secours Richmond Community Hospital LLC Richmond Virginia
United States McGuire VA Medical Center Richmond Virginia
United States VCU Health System Richmond Virginia
United States Velocity Clinical Research, Riverton Riverton Utah
United States Gastroent Consult of SW VA Roanoke Virginia
United States Mayo Clinic Rochester Minnesota
United States UC Davis Hlth -Midtwn Ambu Cen Sacramento California
United States Theia Clinical Research Centers LLC Saint Petersburg Florida
United States University of Utah Salt Lake City Utah
United States Amer. Rrsch Corp-TX Liver Inst San Antonio Texas
United States Clinical Trials of Texas, LLC San Antonio Texas
United States University of California, San Francisco San Francisco California
United States Silicon Valley Res Inst San Jose California
United States Covenant Metabolic Specialists LLC Sarasota Florida
United States Headlands Research - Sarasota Sarasota Florida
United States Louisiana Research Center, LLC Shreveport Louisiana
United States NorthShore Univ Hlth Sys Skokie Illinois
United States Digestive Research Alliance of Michiana South Bend Indiana
United States Premier Health Research, LLC Sparta New Jersey
United States Objective GI Springboro Ohio
United States Mt Olympus Medical Research, LLC Sugar Land Texas
United States Kansas Medical Clinic, PA Topeka Kansas
United States Del Sol Research Management, LLC Tucson Arizona
United States Inst. Liver H II dba AZ Liver H Tucson Arizona
United States Options Health Research, LLC Tulsa Oklahoma
United States ClinCloud, LLC Viera E. Florida
United States CRIOH Westlake Ohio
United States Digestive Hlth Res of N Texas Wichita Falls Texas
United States Florida Medical Clinic, LLC Zephyrhills Florida

Sponsors (1)

Lead Sponsor Collaborator
Novo Nordisk A/S

Countries where clinical trial is conducted

United States,  Argentina,  Australia,  Austria,  Belgium,  Brazil,  Bulgaria,  Canada,  China,  Croatia,  Czechia,  Denmark,  France,  Germany,  Greece,  India,  Ireland,  Israel,  Italy,  Japan,  Korea, Republic of,  Malaysia,  Mexico,  Netherlands,  Norway,  Poland,  Portugal,  Puerto Rico,  Romania,  Russian Federation,  Serbia,  Singapore,  Slovakia,  South Africa,  Spain,  Switzerland,  Taiwan,  Turkey,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Part 1: Resolution of steatohepatitis and no worsening of liver fibrosis (Yes/No) Count of subject From randomisation (week 0) to week 72
Primary Part 1: Improvement in liver fibrosis and no worsening of steatohepatitis (Yes/No) Count of subject From randomisation (week 0) to week 72
Primary Part 2: Cirrhosis-free survival (Yes/No) Count of subject From randomisation (week 0) to week 240
Secondary Change in body weight Percentage From randomisation (week 0) to week 72
Secondary Resolution of steatohepatitis and improvement in liver fibrosis (Yes/No) Count of subject From randomisation (week 0) to week 72
Secondary Change in SF-36 (Short Form 36) Bodily Pain Score points From randomisation (week 0) to week 72
Secondary Change in body weight Percentage From randomisation (week 0) to week 240
Secondary Improvement in steatohepatitis with at least a 2-point reduction in NAS and no worsening of fibrosis (Yes/No) Count of subject From randomisation (week 0) to week 72
Secondary Change in histology-assessed liver collagen proportionate area Ratio to baseline From randomisation (week 0) to week 72
Secondary Worsening in steatohepatitis (Yes/No) Count of subject From randomisation (week 0) to week 72
Secondary Improvement in histology-assessed ballooning (Yes/No) Count of subject From randomisation (week 0) to week 72
Secondary Improvement in histology-assessed inflammation (Yes/No) Count of subject From randomisation (week 0) to week 72
Secondary Improvement in histology-assessed steatosis (Yes/No) Count of subject From randomisation (week 0) to week 72
Secondary NASH resolution (ballooning of 0, inflammation of 0-1) and above or equal to 2point NAS reduction with no worsening of fibrosis Count of subject From randomisation (week 0) to week 72
Secondary Progression of liver fibrosis in patients with F2 at baseline (Yes/No) Count of subject From randomisation (week 0) to week 72
Secondary Progression of liver fibrosis Count of subject From randomisation (week 0) to week 72
Secondary Resolution of steatohepatitis and no worsening of liver fibrosis (Yes/No) Count of subject From randomisation (week 0) to week 240
Secondary Improvement in liver fibrosis and no worsening of steatohepatitis (Yes/No) Count of subject From randomisation (week 0) to week 240
Secondary Changes in liver stiffness values assessed by transient elastography (FibroScan®) Ratio to baseline From randomisation (week 0) to week 72 and week 240
Secondary Change in ELF (Enhanced Liver Fibrosis) score Logarithm From randomisation (week 0) to week 72 and week 240
Secondary Change in ALT (alanine aminotransferase) Ratio to baseline From randomisation (week 0) to week 72 and week 240
Secondary Change in AST (aspartate aminotransferase) Ratio to baseline From randomisation (week 0) to week 72 and week 240
Secondary Change in CAP (Controlled Attenuation Parameter) values assessed by transient elastography (FibroScan) Absolute change From randomisation (week 0) to week 72 and week 240
Secondary Change in FAST (FibroScan-AST) score Probability (absolute change) From randomisation (week 0) to week 72 and week 240
Secondary Change in Pro-C3 (pro-peptide of type III collagen) Logarithm From randomisation (week 0) to week 72 and week 240
Secondary Change in inflammation assessed by hsCRP (High Sensitive C-Reactive Protein) Ratio to baseline From randomisation (week 0) to week 72 and week 240
Secondary Change in HbA1c (glycated haemoglobin) Percentage-points (absolute change) From randomisation (week 0) to week 72 and week 240
Secondary Change in triglyceride Ratio to baseline From randomisation (week 0) to week 72 and week 240
Secondary Change in free fatty acids Ratio to baseline From randomisation (week 0) to week 72 and week 240
Secondary Change in LDL (low-density lipoprotein) cholesterol Ratio to baseline From randomisation (week 0) to week 72 and week 240
Secondary Change in HDL (High density lipoprotein ) cholesterol Ratio to baseline From randomisation (week 0) to week 72 and week 240
Secondary Time to first MACE(Major Adverse Cardiovascular event ) (composite endpoint) Days From randomisation (week 0) to week 240
Secondary Major cardio-hepatic event-free survival (Yes/No) Count of subject From randomisation (week 0) to week 240
Secondary Changes in SF-36 (Short Form 36 v2.0 acute ) Physical Component Summary Score points From randomisation (week 0) to week 72 and week 240
Secondary Changes in SF-36 Mental Component Summary Score points From randomisation (week 0) to week 72 and week 240
Secondary Change in SF-36 Bodily Pain Score points From randomisation (week 0) to week 240
Secondary Changes in NASH-CHECK Abdominal Pain Score points From randomisation (week 0) to week 72 and week 240
See also
  Status Clinical Trial Phase
Recruiting NCT05945537 - A Study of INI-822 in Healthy Volunteers and Participants With Non-alcoholic Steatohepatitis (NASH) or Presumed NASH Phase 1
Recruiting NCT05462353 - Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 Tablets in Adult Patients With NASH Phase 2
Recruiting NCT05065593 - The Effect of Aerobic and Resistant Exercise Training in Patients With Non-Alcoholic Steatohepatitis N/A
Terminated NCT04171765 - A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo in Participants With Non-Alcoholic Steatohepatitis Phase 2
Recruiting NCT04365855 - The Olmsted NAFLD Epidemiology Study (TONES) N/A
Active, not recruiting NCT02912260 - Phase 2 Study of MGL-3196 in Patients With Non-Alcoholic Steatohepatitis (NASH) Phase 2
Recruiting NCT06054815 - Study to Evaluate the Efficacy and Safety of DA-1241 in Subjects With Presumed NASH Phase 2
Completed NCT02784444 - A Study to Evaluate the Safety, Tolerability & Efficacy of MSDC-0602K in Patients With NASH Phase 2
Not yet recruiting NCT06160271 - Study of Liver Fibrosis Stage Assessment by Fibroblast Activation Protein Imaging in Patients With Biopsy for Suspected or Proven Nonalcoholic Steatohepatitis Phase 2
Active, not recruiting NCT05573204 - Comparative Study Between Obeticholic Acid Versus Vitamin E in Patients With Non-alcoholic Steatohepatitis Phase 2
Completed NCT04042142 - Glucagon Resistance in Patients With NAFLD N/A
Completed NCT04657523 - Ultrasound-Based Liver Fat Quantification (LFQ) Pilot Study N/A
Completed NCT04142424 - A Study to Understand the Safety, Tolerability, and Activity of Drug in Body Over a Period of Time of AZD2693, in Subjects of Non-Childbearing Potential in Overweight But Otherwise Healthy Subjects, and Healthy Chinese and Japanese Subjects Phase 1
Terminated NCT02787304 - Volixibat (SHP626) in the Treatment of Adults With Nonalcoholic Steatohepatitis (NASH) Phase 2
Recruiting NCT04666402 - Integrated Diagnostics for Early Diagnosis of Liver Disease
Completed NCT02528305 - The Effect of HIT in Patients With Non-alcoholic Fatty Liver Disease/Steatohepatitis N/A
Recruiting NCT01056133 - Effect of Fish-oil on Non-alcoholic Steatohepatitis (NASH) Phase 2
Completed NCT04806750 - Emricasan, an Oral Caspase Inhibitor, in Subjects With Non-Alcoholic Steatohepatitis (NASH) Cirrhosis and Severe Portal Hypertension Phase 2
Completed NCT02960204 - Emricasan, an Oral Caspase Inhibitor, in Subjects With NASH Cirrhosis and Severe Portal Hypertension Phase 2
Recruiting NCT05751720 - Effect on Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus With Gastric Inhibitory Polypeptide/Glucagon Like Peptide-1 Analogue Phase 1/Phase 2